- Home
- TIRX vs HOTH Comparison
TIRX vs HOTH Comparison
Compare TIRX & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIRX
- HOTH
- Stock Information
- Founded
- TIRX 2010
- HOTH 2017
- Country
- TIRX China
- HOTH United States
- Employees
- TIRX N/A
- HOTH N/A
- Industry
- TIRX Specialty Insurers
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- TIRX Finance
- HOTH Health Care
- Exchange
- TIRX Nasdaq
- HOTH Nasdaq
- Market Cap
- TIRX 4.6M
- HOTH 4.9M
- IPO Year
- TIRX 2021
- HOTH 2019
- Fundamental
- Price
- TIRX $1.67
- HOTH $1.50
- Analyst Decision
- TIRX
- HOTH Strong Buy
- Analyst Count
- TIRX 0
- HOTH 4
- Target Price
- TIRX N/A
- HOTH $4.75
- AVG Volume (30 Days)
- TIRX 493.9K
- HOTH 25.5M
- Earning Date
- TIRX 08-16-2024
- HOTH 11-12-2024
- Dividend Yield
- TIRX N/A
- HOTH N/A
- EPS Growth
- TIRX N/A
- HOTH N/A
- EPS
- TIRX N/A
- HOTH N/A
- Revenue
- TIRX $697,733.00
- HOTH N/A
- Revenue This Year
- TIRX N/A
- HOTH N/A
- Revenue Next Year
- TIRX N/A
- HOTH N/A
- P/E Ratio
- TIRX N/A
- HOTH N/A
- Revenue Growth
- TIRX N/A
- HOTH N/A
- 52 Week Low
- TIRX $1.38
- HOTH $0.58
- 52 Week High
- TIRX $7.40
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- TIRX 48.61
- HOTH 58.81
- Support Level
- TIRX $1.40
- HOTH $1.50
- Resistance Level
- TIRX $1.73
- HOTH $1.71
- Average True Range (ATR)
- TIRX 0.16
- HOTH 0.45
- MACD
- TIRX -0.01
- HOTH 0.04
- Stochastic Oscillator
- TIRX 55.10
- HOTH 25.54
About TIRX TIAN RUIXIANG Holdings Ltd
Tian Ruixiang Holdings Ltd is an Insurance Brokerage firm. It distributes a wide range of insurance products, which are categorized into two groups; property and casualty insurance, such as commercial property insurance, liability insurance, accidental insurance, and automobile insurance; and other insurances, such as health insurance, life insurance, and miscellaneous insurances. It also generates a small amount of revenue from risk management services. The firm act on behalf of its customers seeking insurance coverage from insurance companies. It generates revenue from the provision of insurance brokerage services.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.